Signaturefd, LLC Kodiak Sciences Inc. Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$4.3 - $9.48 $382 - $843	89 Added 185.42%	137 $0
Q1 2023 Apr 28, 2023	SELL	$4.81 - $8.88 $1,750 - $3,232	-364 Reduced 88.35%	48 $0
Q4 2022 Jan 27, 2023	BUY	$6.52 - $8.05 $1,877 - $2,318	288 Added 232.26%	412 $2,000
Q2 2022 Aug 10, 2022	BUY	$5.04 - $9.48 $624 - $1,175	124 New	124 $1,000
Q1 2022 May 02, 2022	SELL	$7.09 - $89.45 $127 - $1,610	-18 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$80.85 - $128.49 $970 - $1,541	12 Added 200.0%	18 $2,000
Q3 2021 Oct 28, 2021	SELL	$81.97 - $106.94 $573 - $748	-7 Reduced 53.85%	6 $1,000
Q2 2021 Jul 26, 2021	BUY	$77.2 - $126.54 $1,003 - $1,645	13 New	13 $1,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.